Niger Med J. 2013 Nov;54(6):426-9. doi: 10.4103/0300-1652.126302.
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Nigerian medical journal : journal of the Nigeria Medical Association
Mathias Abiodun Emokpae, Babatunde Gabriel Adejumol, Aliyu Abdu, Nasiru Magaji Sadiq
Affiliations
Affiliations
- Department of Medical Laboratory Science, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Kano, Nigeria ; Department of Chemical Pathology Aminu Kano Teaching Hospital, Kano, Nigeria.
- Department of Medical Laboratory Science, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Kano, Nigeria.
- Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
- Department of Medical Microbiology Aminu Kano Teaching Hospital, Kano, Nigeria.
PMID: 24665160
PMCID: PMC3948968 DOI: 10.4103/0300-1652.126302
Abstract
BACKGROUND: The frequency of raised serum alpha-fetoprotein may vary in relation to hepatitis B or C infection in chronic liver disease (CLD). The study evaluated the frequency of hepatitis B and C in patients with chronic liver disease and correlated the levels of serum alpha-fetoprotein with hepatitis B and C infection in the patients.
MATERIALS AND METHODS: Eighty-six patients with CLD were recruited for the study. Fifty subjects, with no CLD were used as control. Hepatitis B surface Antigen (HBsAg) and hepatitis C antibody were determined using enzyme-linked immunosorbent assay (ELISA) technique (Human diagnostics, Germany and HCV Murex 40 Anhet laboratories, USA) while liver function tests were evaluated using express plus chemistry auto analyzer. Alpha-fetoprotein was assayed using ELECSYS 1010 auto analyser.
RESULTS: There were 60 males and 26 females, with a mean age of 46 + 6.5 years, while the controls were 25 males and 25 females with a mean age of 41 ± 2.5 years. Thirty-six subjects (41.7%) were seropositive for HBsAg while 24 (27.9%) were seropositive for Hepatitis C Virus (HCV) antibody. The mean alpha fetoprotein level was 359 ± 9.9 ng/mL while mean control value was 1.93 ± 0.24 ng/mL. Liver function test parameters were elevated compared with control subjects (P < 0.001). The increase in serum alpha-fetoprotein was higher (P < 0.001) in HCV than HBsAg positive patients.
CONCLUSION: Serum alpha-fetoprotein level was highest in HCV compared to HBsAg positive and hepatitis negative patients with CLD.
Keywords: Alpha fetoprotein; HBsAg; HCV antibody; chronic liver disease
References
- Mod Pathol. 2010 Feb;23(2):276-83 - PubMed
- J Hepatol. 1998 Jan;28(1):27-33 - PubMed
- Indian J Med Microbiol. 2004 Oct-Dec;22(4):269-70 - PubMed
- Am J Trop Med Hyg. 1993 Apr;48(4):581-4 - PubMed
- J Ayub Med Coll Abbottabad. 2003 Jul-Sep;15(3):54-5 - PubMed
- Hepatology. 1995 Oct;22(4 Pt 1):1101-8 - PubMed
- Am J Prev Med. 1994;10 Suppl:45-55 - PubMed
- Br J Cancer. 1994 Jun;69(6):1157-9 - PubMed
- Epidemiol Infect. 1996 Oct;117(2):327-32 - PubMed
- Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):171-4 - PubMed
- J Hepatol. 1998 Apr;28(4):608-14 - PubMed
- Indian J Med Microbiol. 2005 Oct;23(4):273-4 - PubMed
- PLoS One. 2008 Jun 11;3(6):e2391 - PubMed
- PLoS One. 2012;7(7):e39466 - PubMed
- Hepatology. 1990 Dec;12(6):1420-32 - PubMed
- Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):38-41 - PubMed
- Ann Intern Med. 2006 May 16;144(10):705-14 - PubMed
- J Hepatol. 1994 Aug;21(2):159-66 - PubMed
- West Afr J Med. 1997 Oct-Dec;16(4):198-203 - PubMed
Publication Types